Computational and Experimental Resources for Virome Analysis in Inflammatory Bowel Disease (CERVAID)

炎症性肠病病毒组分析的计算和实验资源 (CERVAID)

基本信息

  • 批准号:
    10019521
  • 负责人:
  • 金额:
    $ 183.23万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-09-18 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

SUMMARY While the role of the bacterial microbiome in human health and disease is well established, few studies have evaluated the contribution of the virome. Recently, we demonstrated that alterations in the enteric virome in adulthood are associated with diseases such as inflammatory bowel disease (IBD) and AIDS. In a cross- sectional comparison of IBD cases and household controls, a significant expansion of the Caudovirales, an order of phages, and anelloviruses, a family of eukaryotic DNA viruses, was observed. Advancing understanding of the IBD virome beyond this finding is limited by: (1) A lack of well defined longitudinal human cohorts to enable discovery of temporal associations of the virome with health and disease; (2) The challenge of viral “dark matter”. Dark matter refers to the typically >50% of the sequences present in purified virus preparations cannot be classified due to a lack of statistically significant alignment to known reference sequences. Thus, current virome studies effectively assess < 50% of the virome, thereby compromising our ability to detect important associations between the virome and disease; (3) Inadequate experimental systems to manipulate the virome. Although sequencing has identified many novel eukaryotic viruses, there are only cell culture systems for a limited number of viruses; moreover, there are no small animal infection models for newly described viruses. In addition while a tremendous diversity of phage has been identified, only a tiny fraction have known hosts and an even smaller fraction has been cultured. Thus, there are significant barriers that must be overcome to be able to experimentally test the impact of either eukaryotic viruses or phages in murine IBD models. These barriers to understanding the role of the IBD virome will be addressed as follows: Aim 1 will define the enteric virome and bacterial microbiome in a longitudinal cohort of IBD patients and household controls and identify virome associations with IBD. In Aim 2 novel computational tools to identify and characterize viruses present in enteric viromes will be developed, including approaches to classify dark matter. In Aim 3 novel experimental systems for functional virome analysis, including novel cultures of both eukaryotic viruses and phages as well as animal infection models, will be developed with the end goal of evaluating causal roles for the viruses and phage in existing muring IBD models. Together, these Aims will not only address significant barriers in understanding of IBD, but will provide a wealth of tangible computational and experimental resources to advance the general field of virome studies.
总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID WANG其他文献

DAVID WANG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID WANG', 18)}}的其他基金

Emerging infections: surveillance, epidemiology and pathogenesis
新发感染:监测、流行病学和发病机制
  • 批准号:
    10626403
  • 财政年份:
    2020
  • 资助金额:
    $ 183.23万
  • 项目类别:
Emerging infections: surveillance, epidemiology and pathogenesis
新发感染:监测、流行病学和发病机制
  • 批准号:
    10163049
  • 财政年份:
    2020
  • 资助金额:
    $ 183.23万
  • 项目类别:
Emerging infections: surveillance, epidemiology and pathogenesis
新发感染:监测、流行病学和发病机制
  • 批准号:
    10633173
  • 财政年份:
    2020
  • 资助金额:
    $ 183.23万
  • 项目类别:
Emerging infections: surveillance, epidemiology and pathogenesis
新发感染:监测、流行病学和发病机制
  • 批准号:
    10403593
  • 财政年份:
    2020
  • 资助金额:
    $ 183.23万
  • 项目类别:
Computational and Experimental Resources for Virome Analysis in Inflammatory Bowel Disease (CERVAID)
炎症性肠病病毒组分析的计算和实验资源 (CERVAID)
  • 批准号:
    10652541
  • 财政年份:
    2019
  • 资助金额:
    $ 183.23万
  • 项目类别:
Computational and Experimental Resources for Virome Analysis in Inflammatory Bowel Disease (CERVAID)
炎症性肠病病毒组分析的计算和实验资源 (CERVAID)
  • 批准号:
    10246192
  • 财政年份:
    2019
  • 资助金额:
    $ 183.23万
  • 项目类别:
Computational and Experimental Resources for Virome Analysis in Inflammatory Bowel Disease (CERVAID)
炎症性肠病病毒组分析的计算和实验资源 (CERVAID)
  • 批准号:
    10474602
  • 财政年份:
    2019
  • 资助金额:
    $ 183.23万
  • 项目类别:
DEFINING NOVEL, EVOLUTIONARILY CONSERVED HOST FACTORS CRITICAL FOR VIRUS INFECTION.
定义对病毒感染至关重要的新型、进化保守的宿主因子。
  • 批准号:
    10399465
  • 财政年份:
    2018
  • 资助金额:
    $ 183.23万
  • 项目类别:
DEFINING NOVEL, EVOLUTIONARILY CONSERVED HOST FACTORS CRITICAL FOR VIRUS INFECTION.
定义对病毒感染至关重要的新型、进化保守的宿主因子。
  • 批准号:
    9918848
  • 财政年份:
    2018
  • 资助金额:
    $ 183.23万
  • 项目类别:
DEFINING NOVEL, EVOLUTIONARILY CONSERVED HOST FACTORS CRITICAL FOR VIRUS INFECTION.
定义对病毒感染至关重要的新型、进化保守的宿主因子。
  • 批准号:
    9595891
  • 财政年份:
    2018
  • 资助金额:
    $ 183.23万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 183.23万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 183.23万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 183.23万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 183.23万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 183.23万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 183.23万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 183.23万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 183.23万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 183.23万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 183.23万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了